Home > Healthcare > Medical Devices > Medical Supplies > Vials Market

Vials Market Trends

Report ID: GMI12130
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Vials Market Trends

Advancements in glass technology are expected to drive market demand, as innovations such as coated and strengthened glass vials enhance durability, drug stability, and safety. These advancements are aimed at meeting the rising requirements of the pharmaceutical and biologics sectors, where high-quality packaging is essential to maintain the integrity of sensitive formulations.

For instance, in October 2024, Nipro entered a new collaboration with Corning Incorporated. This partnership integrates Nipro’s premium glass vials with Corning’s state-of-the-art Velocity Vial coating technology, aiming to drive innovation in the pharmaceutical packaging industry by enhancing vial durability and drug stability.

Enhanced glass technology also reduces the risk of breakage and contamination, making it a preferred choice for injectable drugs and biologics, thereby further expanding market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global vials industry was valued at USD 12.2 billion in 2023 and is estimated to grow at a 9.1% CAGR from 2024 to 2032, driven by the increasing demand for sterile and stable drug storage solutions.

RTU vials segment dominated the market in 2023 and is anticipated to grow at a 9.4% CAGR over the forecast period due to their ability to provide pre-measured doses, reducing preparation time and contamination risks in clinical settings.

U.S. vials market held a leading position in North America in 2023 and is projected to maintain this dominance with a CAGR of 8.8%, driven by its robust pharmaceutical and biotechnology sectors.

Key players in the vials industry include Amcor, Arab Pharmaceutical Glass, Corning Incorporated, Daikyo Seiko, DWK Life Sciences, Gerresheimer AG, KISHORE GROUP, Mitsubishi Gas Chemical Company, Nipro, Pacific Vial Manufacturing, SCHOTT Pharma (SCHOTT Group), and SGD Pharma.